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Abstract 
Background: Antibiotic resistance is fast becoming a major health challenge. Patients need 
to be educated on the origin of this medical crisis and need to change their attitude toward 
antibiotic use. Health professionals need to help patients improve antibiotic compliance and 
identify problem areas.   
Objectives: The aim of this study was to determine whether a better understanding of 
resistance formation and patient education on responsible use of antibiotics will improve 
patient compliance towards antibiotic use. To achieve the aim of the study we determined the 
patient‘s compliance on antibiotic use by the self-pill count feedback method. We further 
determined whether the provision of more antibiotic information to the patient correlated to 
better compliance and other reasons for non-compliance were also recorded. We also 
compared the findings of the study with findings from other similar antibiotic compliance 
studies. 
Methodology: The study was conducted at a private hospital in Gauteng. Patients receiving 
antibiotic prescriptions were divided into two groups. Group A received a leaflet with their 
antibiotic prescription with information on how to use antibiotics responsibly. Group B did 
not receive any additional information on antibiotic use. Both these groups were contacted via 
e-mail and asked to complete a survey to test their knowledge and attitude towards antibiotics. 
Results: A total of 79 patients participated in the study. Group A with 39 participants and 
Group B with 40 participants completed the questionnaire and reported on their antibiotic 
usage and knowledge.  
Group Aa, who was provided additional information on antibiotic use and read through the 
brochure, showed a better compliance to the antibiotic regimen prescribed. When compared to 
Group Ab, who received additional information on antibiotic use and did not read through the 
brochure, and Group B, who received no additional information on antibiotic use, a much 
higher percentage of Group Aa was able to give valid reasons as to why one should complete 
an antibiotic course. 78% of Group Aa intended to change their future behaviour with regards 
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to left-over antibiotics. These patients are committed to being completely compliant in future. 
This group showed a 100% change in attitude when it comes to pressurizing medical 
practitioners into prescribing antibiotics for minor illness, colds and flu. 
The majority of Group Aa admitted to learning something by reading the leaflet handed to 
them and also showed most interest in wanting more antibiotic information from their 
pharmacist in future. Participants gave various reasons for not being compliant. Most patients 
stopped taking their antibiotics as soon as they felt better.  
Participants from Group Aa showed most willingness to learn more about antibiotic use with 
females and children making out the largest portion of the group. Male participants tended to 
be less eager to learn more about responsible antibiotic use. 
The child group that received leaflets with their medication had a 28.21% response rate and 
the group without leaflets had a 28.57% response rate. There is therefore no significant 
difference between the two groups. 
Conclusion: The main objective of the study was to determine whether a better 
understanding to antibiotic resistance will lead to better compliance. The hypothesis H = Ma > 
Mb, where Ma represents Group A and Mb represents Group B of the study, proved to be true. 
Participants from Group A showed a better understanding of the formation of antibiotic 
resistance. This group intended to change their negative behaviour and showed a higher 
compliance rate than Group B. 
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Chapter 1: Introduction and statement of the problem 
 
1.1 Background 
Stokowski (2010) wrote that the word "antibiotic" has always been a symbol of the miracles 
of modern medicine. Perhaps a bit ordinary these days compared with robotic surgery or 
capsule endoscopy, but in a different time, antibiotics literally changed the world. It began in 
1928 when bacteriologist Alexander Fleming serendipitously realized that the growth of 
Streptococcus aureus was inhibited in a petri dish contaminated by mould. Within a few years 
we had sulfa drugs; rapidly followed by more effective beta-lactams, chloramphenicol, 
tetracycline, and by 1950, the aminoglycosides.  
In the past 70 years, antibiotics have been critical in the fight against infectious disease caused 
by bacteria and other microbes. However, disease-causing microbes that have become 
resistant to antibiotic drug therapy are an increasing public health problem. Wound infections, 
gonorrhea, tuberculosis, pneumonia, septicemia and childhood infections are but a few of the 
diseases that have become hard to treat with antibiotics. One part of the problem is that 
bacteria and other microbes that cause infections are remarkably resilient and have developed 
several ways to resist antibiotics and other antimicrobial drugs. Another part of the problem is 
due to increasing use, and misuse, of existing antibiotics in human and veterinary medicine 
and in agriculture. The problem of antimicrobial resistance stems primarily from antibiotic 
usage (Todar 2004).  
Hippocrates described the importance of patient compliance over 2000 years ago. Hippocrates 
advised a physician, ―…to be alert to the faults of the patient which make them lie about their 
taking of the medicines prescribed and when things go wrong, refuse to confess that they have 
not been taking their medicines‖ (Murphy 2007). 
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Patient may follow prescription orders in different ways. Some will follow instructions to the 
letter, some patients will follow some of the instructions for some time and others will not 
follow any instruction. 
Compliance or the lack thereof affects us all. One of the most understated problems in the 
delivery of health services is patient non-compliance, its occurrence and impact on the health 
services and its associated outcomes if allowed to continue without intervention (Fincham 
2007). 
Compliance and adherence relate to the medicine-taking behaviour of the patient. This can be 
estimated using prescription claims records, pharmacy dispensing data, validated survey 
instruments or electronic pill counters, as well as direct measures such as serum concentration 
levels of medication taken by the patient (Bell et al 2007). 
Despite doctors‘ expectations, non-compliance is common in short-term antibiotic therapy of 
respiratory tract infections. This phenomenon has profound practical implications. It leads to 
ineffective management, the deterioration of patients‘ health, hospital admissions, additional 
costs and the emergence of antibiotic-resistant micro-organisms (Kardas 2002). 
Non-compliance is defined as any deviation by a patient from a doctor‘s instructions. Non-
compliance with medications is particularly important in clinical practice. This form of non-
compliance has been found to be associated with treatment failure and all its consequences, 
namely: deterioration of patients‘ health, the need for additional consultations, the use of extra 
drugs, additional hospital admissions as well as an increase in direct and indirect costs of the 
management of the treated condition (Kardas 2002).  
In the case of antibiotic therapy, the right choice of medication, taking into account the 
pathogen‘s susceptibilities and appropriate dosage are especially important. The misuse of 
antibiotics for viral infections and the excessive use of broad spectrum antibiotics in place of 
narrower spectrum antibiotics have been well-documented throughout the world (Kardas 
2002). 
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1.2  Statement of the problem 
Working in a pharmacy one often find that patients recognise antibiotics being dispensed to 
them, stating that they do not need a whole course as they still have some at home from a 
previous prescription filling. At times patients would call the pharmacy, having gone through 
the medicine-cabinet, wanting to know what conditions they can use left-over antibiotics for.  
In these conversations one has come to realise that patients do not have an understanding of 
why they need to finish antibiotic courses and how antibiotic resistance develops. 
The problem of antibiotic resistance is related to antibiotic misuse, for instance antibiotic use 
in the case of viral infections. It also stems from antibiotic overuse due to patients pressuring 
medical practitioners for antibiotic prescriptions in minor infections as well as medical 
practitioners prescribing ineffective antibiotics and ineffective doses of antibiotics. 
It is evident that patients need to be educated on responsible antibiotic use. We are facing a 
huge health problem when it comes to antibiotic use and resistance development. I believe 
that we can make a difference in the use of antibiotics by educating patients on the use of 
antibiotics and antibiotic resistance. 
1.3  Antibiotic resistance 
Sir Alexander Flemming said ―The greatest possibility of evil in self-medication is the use of 
too small doses so that instead of clearing up infection, the microbes are educated to resist 
penicillin and a host of penicillin- fast organisms is bred out which can be passed to other 
individuals and from them to other until they reach someone who gets a septicemia or a 
pneumonia which penicillin cannot save.‖ (Noreddin n.d). This was already the beginning of 
antibiotic resistance formation.  
Antibiotics are responsible for huge advances in medicine, however, their use selects for 
resistant bacteria and once selected, these bacteria can transfer their resistant genes to new 
generations, resulting in reduced future efficacy and decreased sensitivity of antibiotics. There 
are currently resistant strains of nearly all bacteria (Jackson et al. 2006). 
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The emergence of antibiotic resistance is an evolutionary process that is based on selection for 
organisms that have enhanced ability to survive doses of antibiotics that would have 
previously been lethal (Cowen 2008). Antibiotics like penicillin and erythromycin, which 
used to be one-time miracle cures are now less effective because bacteria have become more 
resistant (Pearson 2007). Antibiotics themselves act as a selective pressure that allows the 
growth of resistant bacteria within a population and inhibits susceptible bacteria (Levy 1994). 
An alarming increase in resistance of bacteria that cause community acquired infections has 
been documented. In a recent study, 25% of bacterial pneumonia cases were shown to be 
resistant to penicillin, and an additional 25% of cases were resistant to more than one 
antibiotic (Todar 2004). 
 
Resolving or lowering the incidence of the problem of antibiotic resistance is considered to be 
an international public health challenge (Jacson et al. 2006). Inappropriate prescribing of 
antibiotics and non-compliance to antibiotic prescription regimens are the most important 
human attributes to antibiotic resistance formation. 
Inappropriate prescribing of antibiotics has been attributed to a number of causes including: 
patients who insist on antibiotics, physicians who prescribe antibiotics as they feel they do not 
have time to explain why they are not necessary and medical practitioners who do not know 
in which case to prescribe antibiotics or else are overly cautious for medical legal reasons 
(Arnold & Straus 2005). 
A third of people for example believe that antibiotics are effective for the common cold and 
22% of people do not finish a course of antibiotics primarily due to that fact that they feel 
better (varying from 10% to 44% depending on the country) (Todar 2004). 
1.4 Antibiotic non-compliance  and reasons for non-compliance  
Studies in the United States of America (USA) have shown that patient adherence to a 
prescribed antibiotic regimen is as little as 50%. Non-adherence increase medical expenses 
and costs the USA as much as $100 billion annually (Brown & Goff 2005).  
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Patients take their prescribed antibiotic course only until they feel better, and then stop. They 
save the rest of their medication in case they or their family members have a similar illness in 
the future. Non-adherence to antibiotic regimens has an effect beyond each individual 
patient‘s therapeutic outcome. It has a very important effect on resistance patterns. A study 
has shown that poor adherence to the prescribed antibiotic regimen is also one of the major 
factors influencing treatment failure not relate$ to resistance (Brown & Goff 2005).  
Compliance depends on many factors, and in different studies different values of compliance 
are obtained.  
1.5 Patient Education 
Concordance refers to the nature of the interaction between the clinician and the patient. A 
greater interaction between the healthcare practitioner and the patient ensures a better 
understanding of why compliance to the treatment-plan in important (Bell et al. 2007). 
In 1999 the Department of Health in the United Kingdom launched a National Public 
Awareness Campaign on antibiotic resistance. The public information campaign aimed  to 
support health professionals by reducing patients‘ expectations for an antibiotic prescription, 
by raising awareness and provide education about the problem of antibiotic resistance, to 
increase understanding about the appropriate use of antibiotics and to increase understanding 
about when antibiotics will be effective or necessary. The campaign was personalized by the 
creation of Andybiotic, a character symbolizing antibiotics in animated form, and expressing 
the words ‘Don't wear me out’ to introduce the topic of sensible use of antibiotics. The 
campaign included posters in general practice surgeries and public places, and patient 
information leaflets given to patients instead of an antibiotic prescription (McNulty et al. 
2007).  
To inform ongoing publicity campaigns, to which The Specialist Advisory Committee on 
Antimicrobial Resistance (SACAR) was committed, in 2003 the Department of Health funded 
a large antibiotic survey of British households. The aims of the survey were to:  
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 Determine the publics' awareness of good antibiotic use and relate this to household 
characteristics.  
 Identify respondent characteristics that explain variation in attitudes to antibiotics.  
 Determine the impact of the Andybiotic campaigns.  
1.6 Combating antibiotic resistance   
 
The following are recommendations to combat the development of antibiotic resistance in 
bacteria and other micro-organisms (Todar 2004). 
 
 Search for new antibiotics. To combat the occurrence of resistant bacteria, 
biotechnology and pharmaceutical companies must constantly research, develop and 
test new antimicrobials in order to maintain a pool of effective drugs on the market.  
 
 Stop the use of antibiotics as growth-promoting substances in farm animals. Of major 
concern is the use of antibiotics as feed additives given to farm animals to promote 
animal growth and to prevent infections rather than cure infections. The use of such 
antibiotics contributes to the emergence of antibiotic-resistant bacteria that threaten 
human health and decreases the effectiveness of the same antibiotics used to combat 
human infections. 
 Use the right antibiotic in an infectious situation as determined by antibiotic sensitivity 
testing, when possible.                                                                                                 
 Stop unnecessary antibiotic prescriptions. Unnecessary antibiotic prescriptions have 
been identified as causes for an enhanced rate of resistance development. Unnecessary 
prescriptions of antibiotics are made when antibiotics are prescribed for viral 
infections (antibiotics have no effect on viruses). This gives the opportunity for 
indigenous bacteria (normal flora) to acquire resistance that can be passed on to 
pathogens. 
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 Finish antibiotic prescriptions. Unfinished antibiotic prescriptions may leave some 
bacteria alive or may expose them to sub-inhibitory concentrations of antibiotics for a 
prolonged period of time. Mycobacterium tuberculosis is a slow growing bacteria 
which infects the lung and causes tuberculosis. This disease kills more adults than any 
other infectious disease. Due to the slow growing nature of the infection, treatment 
programs last for months or even years. This has led to many cases on unfinished 
prescriptions and 5% of strains now observed are completely resistant to all known 
treatments and hence incurable. 
 
 Large scale public health education efforts are underway to stress the importance of 
finishing prescriptions. Indeed, in many places, failure to finish tuberculosis 
prescriptions can result in jail time.  
 
In the pharmaceutical industry, past and current strategies to combat resistance have not been 
effective. Pharmaceutical companies are seeking new, less costly strategies to develop 
antibiotics. Several countries such as the UK have regulations concerning the use of 
antibiotics in animal feed.  
1.7 Aim of the study 
The aim of this study was to determine whether a better understanding of resistance formation 
and patient education on responsible use of antibiotics will improve patient compliance 
towards antibiotic use. 
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1.8 Objectives of the study 
To achieve the aim of the study we determined the patient‘s compliance on antibiotic use by 
the self-pill count feedback, determined whether the more antibiotic information to the patient 
correlated to better compliance and recorded any other reasons for non-compliance. We also 
compared the findings of the study with findings from other similar antibiotic compliance 
studies. 
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Chapter 2: Literature review 
Medication non-compliance may occur at different points in a patient‘s decision-making 
process. It may take place at the start of therapy if a patient does not fill a prescription, or it 
may occur after therapy has started when the patient fails to follow the instructions.  
Patients‘ compliance with medication is a prerequisite for effective drug therapy. Antibiotic 
non-compliance is a major public health problem that imposes a considerable financial burden 
on the health care system.  
 
2.1 Patient related factors and non-compliance 
Patient characteristics have been the focus of numerous investigations of compliance. Non-
compliance can be of an initial, intentional or unintentional type or of premature 
discontinuation. Initial non-compliance rates of about 13 to 25 percent are reported where the 
prescription never reached the pharmacy for filling. The variations in patient compliance are a 
function of methodological and contextual factors in compliance research. It is important to 
research the enabling patient attributes, which is the first step to designing effective 
interventions (Fincham 2007). 
Socioeconomic status has not consistently been found to be an independent predictor of 
compliance. Some factors that are reported significant are: poor socioeconomic status, 
poverty, illiteracy, low level of education, unemployment, lack  of effective social support 
networks, unstable living conditions, distance from treatment centre, high cost of 
transportation, high cost of medication, changing environment situations as well as culture 
and lay beliefs about illness and treatment. Income specifically and not general 
socioeconomic status has a positive and significant effect on patient compliance (Fincham 
2007). 
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Patient related factors affecting compliance are forgetfulness, psychosocial stress, 
misunderstanding and non-acceptance of the disease, disbelief in the diagnosis, lack of 
perception of the risks related to the disease, misunderstanding of the treatment instructions, 
lack of acceptance of monitoring, low treatment expectations, lack of self perceived need for 
treatment, lack of perceived effect of treatment, negative beliefs regarding the effect of 
treatment, anxieties about possible adverse effects, low motivation, inadequate knowledge of 
treatment, low attendance at counselling, frustration with health care providers, fear of 
dependence and over complexity of the regimen (Fincham 2007) 
 
2.2 Past studies on antibiotic non-compliance 
A large, country-wide German study recently assessed compliance rates among children 
treated with antibiotics for various infections.  A urine test confirmed the presence of 
antibiotic in 69.5% patients (Kardas 2002). 
Brown and Goff (2005) found that the length of the antibiotic course as well as the frequency 
of the dosage intervals influence adherence. It was also found that income, social class, 
occupation and educational background did not determine adherence. The classic scenario is 
that patients take their prescribed antibiotic course only until they feel better, and then stop.  
A major factor influencing compliance is the frequency of doses. Numerous studies show that 
the less frequent the doses, the higher the compliance. A review of over 100 studies by 
Greenberg (1984) i.e. before the era of electronic measurement, confirmed this tendency. The 
average compliance was 73% for once daily dosing regimens, 70% for twice daily dosing, 
52% for three times daily dosing and 42% for four times a day regimens. The difference 
between compliance with once daily and twice daily dosing regimens was not significant, but 
more frequent dosing was associated with significantly worse compliance rates (Kardas 
2002).  
A literature review performed recently took into account only the studies that used electronic 
devices for compliance measurement. The 76 publications available to date were analysed. 
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Compliance decreased with increased complexity of regimen and was 79% ± 14% for once 
daily dosing, 69% ± 15% for twice daily dosing, 65% ± 16% for three times daily dosing and 
51% ± 20% for four times a day dosing. The difference in compliance between once daily and 
twice daily dosing was not statistically significant (Claxton et al. 2001).  
The highest compliance during antibiotic therapy is also associated with once daily dosing; 
with more frequent dosing compliance decreases. However, compliance rates observed in 
antibiotic treatment of respiratory tract infections tends to be much better than those observed 
with other medications. In the case of a once daily antibiotic regimen, compliance reaches 
values approaching 100% (Kardas 2002).   
More frequent dosing is generally associated with worse compliance in antibiotic therapy. 
When patients were randomly prescribed antibiotics with the dosage in the range 1–3 doses 
per day, increasing complexity of the regimen significantly decreased the probability that the 
patient would not miss any doses of the course. Based on the data collected for short-term 
antibiotic therapy, increasing the number of doses to be taken daily by one increased the 
probability of a patient being non-compliant by 72% (Cockburn et al. 1987).  
Cook et al. (1996) showed that, for twice daily and three times daily Augmentin®, the 
compliance rate was 90% and 87%, respectively. During a 5-day treatment for respiratory 
tract infections, at least one dose was missed by 34% of patients in a twice daily regimen, and 
by 76.5% of patients taking the medication three times a day. Electronic measurement 
revealed that 70% of patients taking trimethoprim twice daily for respiratory tract infection 
therapy were fully compliant, compared with only 39% of patients taking cephalexin four 
times a day. When antibiotic suspensions for children were given twice daily, compliance was 
higher than with thrice daily regimens. Of the patients taking antibiotics four times a day for a 
5-day therapy, none took all of the recommended doses. 
More than 50% of interviewees in a Pan-European study (Branthwaite & Pechère 1996) 
admitted to pressuring their general practitioners to prescribe antibiotics believing that they 
should be prescribed for most respiratory tract infections. The majority of patients waited 2-3 
days before consulting their doctor and over 80% of respondents expected symptoms to 
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improve after 3 days of treatment. This provided evidence for poor compliance, with most 
patients stopping after 3 days because they felt better.  
Compliance depends also on the length of treatment. This general rule is confirmed in 
antibiotic therapy for respiratory tract infections. Better compliance was observed for 
regimens shorter than 7 days duration compared with longer ones. In a study assessing 
compliance during treatment with penicillin for streptococcal infections by tablet count, on the 
third day of treatment 44% of children were fully compliant, on the sixth day 29% and on the 
ninth day only 18%.  In another study of children taking oral penicillin for ß-haemolytic 
streptococcal infection, 81% of patients were taking the antibiotic on the fifth day, but only 
56% on the ninth day. Similar results were achieved by Schrag et al. (2001), who studied 
children aged 6–59 months treated for pneumococcal infection with amoxicillin 90 mg/kg/day 
for 5 days or with 40 mg/kg/day for 10 days. Compliance in this study was significantly better 
at 82% for the shorter therapy compared with the longer course with only 74% compliance. 
Among children receiving antibiotic for the longer period, compliance was significantly 
higher (79%) for days 0–5 compared with days 6–10 (57%). 
There are other factors influencing compliance associated with the convenience of therapy. In 
a study that investigated the relationship between compliance and the form of medication in 
children aged between 2 months and 5 years, given for pneumonia, the results were as 
follows: by the fourth day, 82% of patients taking a syrup continued to take their antibiotics, 
compared with 71% and 55% of patients who took their medication in the form of sachets and 
tablets, respectively. Compliance had a strong link to the parents‘ impression of the ease or 
difficulty of administering the drug (Ellerbeck et al.1995).  
Favre et al. (1997) found the most common mistake is the omission of single doses of 
antibiotics. Some patients take additional doses of antibiotics, especially at the beginning of 
the treatment. This may be associated with severity of the symptoms and the patients‘ desire 
to get better promptly. A premature halt in taking medication is also characteristic in antibiotic 
treatment. One reason behind it could be symptomatic relief occurring before the 
recommended treatment time elapsed, especially in cases of milder infections. Another reason 
could be the occurrence of adverse effects, which force patients to stop therapy. Large and 
difficult-to-swallow pills or the unpleasant flavour of a suspension may also lead to non-
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compliance. Another type of mistake is caused by changes to the dosing regimen. Some 
patients decrease the frequency of their doses, for example twice a day instead of three times a 
day. 
Some patients who are prescribed antibiotics do not file the prescription with a pharmacist. 
They believe that antibiotics may be harmful to the gastrointestinal tract or the immune 
system. These patients want to see whether the infection resolves without treatment, and so 
delay the start of the therapy. In the case of antibiotic treatment, as with other therapies, 
conscious omission of single doses of the medication takes place. The reasons frequently 
given by patients include fear of interactions with alcohol or other medications (Kardas 2002). 
A major factor influencing compliance is the frequency of doses. Numerous studies show that 
the less frequent the doses, the higher the compliance. Compliance decreased with increased 
complexity of regimen. Compliance depends also on the length of treatment. Better 
compliance was observed for regimens shorter than 7 day duration compared to longer than 7 
days. There are other factors influencing compliance associated with the convenience of 
therapy. Compliance was significantly associated with the parents‘ impression of the ease or 
difficulty of administering the drug (Kardas 2002). 
In some studies the influence of other factors on compliance has been noticed. Compliance 
was higher if the infection was localized to the lower respiratory tract or the patients thought 
that they had a severe disease. It has also been observed that compliance depended on the 
length of time for which the general practitioner had been practising; patients treated by 
younger doctors being significantly more compliant. In another study, it was found that 
compliance in the case of children taking penicillin was higher if the GP had been looking 
after that family for no more than 4 years. On the other hand, non-compliance is associated 
with poor communication between doctor and patient. It was shown that compliance with 
antibiotic therapy improved if the patient thought that he knew the prescribing doctor well. In 
a study performed in Mexico, Reyes et al. (1997) showed that patients were more likely to be 
non-compliant if they did not know the name of the prescriber.  
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Mistakes involving the administration of antibiotics at times other than those recommended 
are common. Several studies showed that compliance in taking antibiotics was very high but 
complying with the correct dosing times was much lower (Kardas 2002).    
Unlike Fincham (2007), numerous studies have shown that compliance did not depend on 
patients‘ age, gender, marital status, education, income or social class. Similar findings were 
discovered in the case of antibiotic therapy, where again compliance did not depend on 
patients‘ gender, marital status or education. Likewise, the degree of non-compliance during 
antibiotic therapy was not related to the cost of the medication to the patient or to whether or 
not the medication was free of charge (Kardas 2002).   
Compliance depends on many factors, and in different studies different values of compliance 
are obtained. 
Fincham (2007) found the following to be factors affecting compliance:  
 Satisfaction with care: The more the care provided in a patient centred approach, the 
greater the patient satisfaction and likelihood of compliance. 
 Communication: Communication must be seen as the key component for increasing 
compliance. 
 Age: The age of patients have been shown to positively affect, negatively affect or 
have no affect on compliance. The majority of studies have shown no significant 
correlation between age and compliance. 
 Gender: Gender has not been shown to be a reliable predictor of compliance.  
 Cost: Compliance has been shown to be negatively affected by the high cost of 
medication.  
 Knowledge of the disease: Knowledge on the causation, prognosis and cure 
possibilities of a particular disease have been shown to positively affect patient 
compliance. 
 Income: Income has been directly related to patient compliance and could be linked to 
the cost of medication. 
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 Continuity of physician-patient relationship: The presence of a continuous physician-
patient relationship has been shown to have a positive influence on patient 
compliance. 
 Medication errors: Medication errors proved to have a negative effect on patients and 
their compliance  
 
2.3 Past studies on patient attitudes to antibiotics 
A study was carried out to determine patient perceptions of respiratory tract infections and 
attitudes to taking antibiotics, thus helping doctors to have a better understanding of their 
patients and their requirements. Telephone interviews were conducted in the United 
Kingdom, Belgium, France, Italy, Spain and Turkey using standardized questionnaires 
directed at patients who had taken an antibiotic or given one to their child for a respiratory 
tract infection within the previous 12 months. Pressure on general practitioners to prescribe 
antibiotics was highlighted by over 50% of interviewees' believing that they should be 
prescribed for most respiratory tract infections. Although interviewees were positive about 
antibiotics, with over 75% judging them to be effective and to speed recovery, some 
ambivalence was shown. Most patients waited 2-3 days before consulting their doctor to see if 
their symptoms would improve and over 80% of respondents expected symptoms to improve 
after 3 days' treatment. This provided a natural watershed for compliance, with most 
defaulters stopping after 3 days because they felt better. Second only to fewer side-effects, 
patients ranked shorter and more convenient dosage alongside efficacy as the improvements 
most sought in antibiotic therapy (Branthwaite & Pechère 1996).  
A household survey in Britain in 2003 found that 79% of respondents were aware that 
‗antibiotic resistance is a problem in British hospitals‘, 38% of respondents did not know that 
antibiotics do not work against most coughs or colds and 43% did not know that ‗antibiotics 
can kill the bacteria that normally live on the skin and in the gut‘. Respondents with lower 
educational qualifications were less knowledgeable about antibiotics. During this study, in a 
multivariable analysis, better knowledge of antibiotics was not associated with being less 
likely to be prescribed any in the last year, but was independently associated with being more 
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likely to finish a course of antibiotic as prescribed. Being more knowledgeable on antibiotics 
was also associated with being more likely to take antibiotics without a doctor‘s instructions. 
In women, better knowledge was associated with being more likely to give an antibiotic to 
someone else that was not prescribed for them. The study has shown that there was no simple 
relationship between increased knowledge and more prudent antibiotic use (McNulty et al. 
2007).  
Patients who were prescribed antibiotics immediately for a sore throat stated that they were 
more likely to consult a health professional to request antibiotics the next time they developed 
a sore throat. Presumably patients believe that antibiotics aided their recovery, and therefore 
need to attend the surgery for antibiotics the next time they get the same condition. Clinicians 
report that they often prescribe antibiotics because they perceive that patients want antibiotics 
(Kardas 2002). 
General practice consultation data indicate that young women have a higher consultation rate 
than other groups of patients.  In a bid to reduce the patient expectation for antibiotics, in the 
autumn of 1999, the British Department of Health (DH) launched a National Public 
Awareness Campaign on antibiotic resistance targeted particularly at these young women and 
mothers. The public information campaign aimed to support health professionals by reducing 
expectations for an antibiotic prescription, by raising awareness about the problem of 
antibiotic resistance, to increase understanding about the appropriate use of antibiotics and, in 
particular, to increase understanding about when antibiotics will not do any good. An 
unpublished 1999 DH survey showed that immediately after the campaign there was more 
public awareness of antibiotic resistance and the public were less likely to expect to receive 
antibiotics from their GP. Therefore, the campaign was repeated in the spring of 2002 
(McNulty et al. 2007).   
 In the McNulty et al. (2007) survey, respondents were asked whether they agreed or 
disagreed with 11 statements about antibiotic use, antibiotic resistance and activity. The 
respondents mostly knew that overuse of antibiotics increased resistance, and that antibiotic 
resistance is increasing. Only 8% of respondents did not agree with the statement that ‗If taken 
too often antibiotics are less likely to work in the future‘, 16% did not agree that ‗Bacteria are 
becoming resistant to antibiotics‘ and only 19% did not agree that ‗antibiotic resistant bacteria 
 - 17 - 
could infect me or my family‘. Respondents also knew the principles of prudent antibiotic use, 
as only 3% did not agree with the statement ‗A course of antibiotics should always be 
completed‘ and the same percentage did not agree that ‗Antibiotics should not be taken 
unnecessarily‘ (McNulty et al. 2007).  
Thirty-two percent of respondents incorrectly agreed that ‗Antibiotics work on most coughs 
and colds‘ and 43% agreed with the statement that ‗Antibiotics can kill viruses‘. This indicates 
that there is a substantial group of the British public who believe that antibiotics will be of 
value when they have a cough or cold and are therefore still likely to request antibiotics from 
clinicians when they have these conditions. The survey also revealed a lack of understanding 
about the differences in activity of antibiotics against bacteria and viruses. In fact a fifth of 
respondents did not agree with the statement ‗Antibiotics can kill bacteria‘. In any future 
antibiotic educational campaigns, it will be important to explain the difference between 
viruses and bacteria, or discuss the need for antibiotics in relation to the severity of infection 
or syndrome, rather than the type of microbe responsible (McNulty et al. 2007). 
Those less knowledgeable about antibiotics were typically less well educated. For each of the 
11 statements, respondents with no formal qualifications were about twice more likely to 
respond incorrectly than respondents with a degree level of education. In an analysis, lower 
educational qualifications were the greatest determinant of lack of knowledge about 
antibiotics. Other subgroups less knowledgeable about antibiotics were the young (16–24 
years) and the old (>75 years). The study results indicate that educational campaigns aimed at 
improving knowledge about antibiotics should be targeted at these less knowledgeable groups 
(McNulty et al. 2007).  
The majority of respondents prescribed an antibiotic in the last year completed the course; 
however, 11.3% reported that they did not finish their last antibiotic course as prescribed. 
When asked why they did not finish the course, 65% reported that it was because they felt 
better or forgot to take them. Two per cent did not start the course at all,  and the same 
percentage reported that the antibiotics did not work. 19% stopped them because of side 
effects. Interestingly, 87% of respondents who did not complete their last course also said that 
a course of antibiotic should always be completed. This suggests that most of those who did 
not complete their course did so knowing that they should have done (McNulty et al. 2007). 
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Almost 16% reported that they have kept an antibiotic in the past; 31% in case they needed 
them again and 8% in case the same infection recurred. Respondents who reported keeping 
left-over antibiotics tended to be younger (12% of 16–24 year olds kept left-over antibiotics 
from their last course, compared to 2% of all those over 55 years old  
This reported behaviour about compliance with prescribed antibiotics concurred with the 
antibiotic audit, in which it was found that 4.3% of those prescribed an antibiotic in the last 
year had a residual antibiotic in the household which had been prescribed for them in the last 
year. Of the 6983 households, 19% had an antibiotic or antifungal. Of all antibiotics, almost 
half were not currently in use, 31% were reported by respondents to be left-over and 18% 
were kept for standby use. Almost half of left-over antibiotics had more than half of the 
original prescription remaining and 38% were prescribed more than 1 year earlier (McNulty et 
al. 2007).  
Almost 5% of respondents reported that they had at some time in the past taken an antibiotic 
without advice from a doctor, nurse or dentist. Many of these antibiotics were taken for 
respiratory infections and 49% were taken for the same infection for which they were 
originally prescribed. Being more educated and being more knowledgeable about antibiotics 
were independently associated with keeping left-over antibiotics and taking antibiotics without 
advice (McNulty et al. 2007). 
2.4 Role of the Pharmacist 
Compliance can be a problem which may go undetected. It is a complex problem affected by 
various factors. Antibiotic compliance can be improved with the help of a pharmacist.  
When non-compliance is recognized, the pharmacist is in a good position to offer support to 
the patient. The approach should be to attempt to remove obvious barriers to compliance. 
Compliance will most likely increase when a concordant approach is adopted. However, for 
the pharmacist to provide advice that is consistent with the treatment-plan of the physician, 
mechanisms will have to be developed for the sharing of information. Depending on the 
nature of the problem, counselling by the pharmacist may assist in improving compliance. At 
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other times input from the whole health-care team may be required to influence patient 
compliance (Winfield & Richards, 2004). 
In the McNulty et al. (2007) survey it was found that to ensure maximum compliance, 
patients should receive adequate information on adverse effects and their influence on the 
treatment. Patients should be educated on antibiotic resistance, antibiotic spectrums as well as 
the length of treatment. 
 
2.5 Patient Education 
In 2003 the Department of Health (DH) survey, respondents were shown the Andybiotic 
Campaign patient information leaflet from a survey done in 1999 and asked if they had seen 
the leaflet or seen or heard anything about the Andybiotic Campaign.  Penetration of this 
campaign was poor, as only a fifth of English respondents and only 25% of respondents who 
had been prescribed an antibiotic in the past year, had seen or heard of the campaign. This is 
disappointing as the campaign was concentrated in General Practitioner surgeries. The 1999 
campaign was accompanied by DH public statements and advertising, but the later campaigns 
were lower key and restricted by financial constraints. Experience with social marketing for 
other health issues such as alcohol and driving shows that campaigns must be sustained over 
several years and include television slots to have a prolonged impact (McNulty et al. 2007).   
Although a third of the public still believe that antibiotics work against coughs and colds, 
simply getting the public to believe otherwise may not be enough to reduce the level of 
prescribing. We have shown that those with a greater knowledge about antibiotics are no less 
likely to be prescribed an antibiotic. And in respect of how the public use the antibiotics they 
are prescribed, sometimes increased knowledge is associated with more prudent use or higher 
chances to self-medicate (McNulty et al. 2007).   
Greater knowledge about antibiotics was associated with a greater tendency to keep left-over 
antibiotics and use them without advice from a clinician. Unnecessary use of left-over 
antibiotics may increase antibiotic resistance in the community's commensal flora by exerting 
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a selective pressure in the gut, skin and upper respiratory tract, favouring bacteria resistant to 
the antibiotics. This audit showed that 10% of households have access to left-over or standby 
antibiotics or anti-fungals. Perhaps, the easiest way to reduce the use of left-over antibiotics is 
to shorten the course of antibiotics prescribed to 3 or 5 days. A recent International survey 
showed that respondents living in countries that dispensed antibiotics in set pack sizes were 
more likely to have left-over antibiotics and use them without advice than respondents living 
in countries where antibiotic courses were dispensed according to the number of days stated 
by the clinician (Kardas et al. 2002).  
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Chapter 3: Methodology 
 
3.1 Study design 
The design of the study was retrospective and mainly quantitative. Some qualitative aspects 
were investigated with regards to reasons for non-compliance and the effect that the 
educational facet of the study had on the patient‘s view on antibiotic non-compliance. 
 
3.2 Study setting 
The study was conducted at a private hospital pharmacy in Pretoria, South Africa. The 
hospital is located in a wealthy, educated community. Although the pharmacy caters for the 
local community, patients from all walks of life and other areas visit the hospital.  
Patients from foreign countries, mining towns and Workers Compensation dependants are 
discharged from the hospital with to take out (TTO) medication and consult doctors at their 
rooms at the hospital. All of these patients collect antibiotic prescriptions from the hospital 
pharmacy. 
 
3.3 Study Method 
Patients receiving antibiotic prescriptions from the study site were identified to form part of 
the research study. Two study groups were formed. Group A received their antibiotics with 
additional information on the responsible use of antibiotics and Group B only received their 
antibiotics and no additional information on antibiotic use. The additional information was 
handed to the patient in the form of an antibiotic information leaflet. 
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There were no costs involved in selecting these groups. As part of routine dispensing practice, 
proper patient counselling was provided to both groups. Patient counselling included 
information on the length of the antibiotic course and that the course should be completed. 
Pharmacist spent a moment to explain the necessity to read through the information leaflet 
handed to Group A. 
Pharmacists then collected the patient‘s e-mail address as patients were sent a cover-letter 
with an e-mail survey. Electronic surveys have very little costs to consider and are a fast way 
to reach the patient and get the response.  
 
3.4 Study population 
Sampling method: 
The selection of the two groups took place in the following manner: 
Group A:  
Every first and third week of the months of October 2009 to July 2010, excluding the month 
of December 2009, an information leaflet was handed out to various patients who received 
oral antibiotics at the pharmacy. The patient‘s attention was drawn to the content of the leaflet 
and the patient was asked to read the leaflet on their own time. The patient was then asked for 
an e-mail address. Copies of these prescriptions with the e-mail addresses were collected. 
Patients were contacted via e-mail a week after the antibiotics have been collected.  
Group A were asked to participate in an electronic survey by completing a questionnaire 
concerning their antibiotic course and their knowledge on antibiotic use (Annexure A and 
Annexure B). 
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Group B:  
During every second and fourth week for the months of October 2009 to July 2010, excluding 
the month of December 2009, patients who received antibiotics from the pharmacy were 
asked for their e-mail addresses. No additional information leaflet regarding responsible 
antibiotic use was given to these patients. Copies of these prescriptions together with the e-
mail addresses were also collected. 
Group B were asked to participate in an e-mail survey by completing the questionnaire 
concerning their antibiotic course and knowledge on antibiotic use.  
All patients who received oral antibiotics with an e-mail address yielded candidates for the 
survey. 
Pharmacists handing out the information and collecting e-mail addresses were asked to do so 
without bias, including all patients from all possible backgrounds. Patients were not told 
about the study until they were contacted via e-mail to complete the questionnaire. This was 
so that patients‘ adherence could be measured against the influence of the educational leaflet 
that they have or have not received, and not the knowledge that they would be contacted in 
connection with their antibiotic course. Informing the patient beforehand about the possibility 
that they would be contacted might have influenced their antibiotic use. 
All antibiotics prescribed as immediate doses were excluded. 
Prescriptions for oral antibiotic courses were used for data collection. This excluded antibiotic 
treatment of Tuberculosis treatment and malaria prophylaxis. 
Participants were contacted via e-mail and asked to partake in an electronic survey. The 
patients were assured of their confidentiality and purposes of the survey. 
A cover letter was sent with the questionnaire survey. Participants gave consent on completing 
the questionnaire and resending the response to the researcher.  
Parents or guardians responded to the survey on prescriptions for their children. 
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3.5 Research hypothesis 
The research hypothesis states that patients who receive better education regarding 
responsible antibiotic use will be more compliant in the use of this medication group. 
Compliance to the prescribed antibiotic regimen was measured by means of patient‘s self-pill-
count and completion of the antibiotic course. 
H = Ma > Mb 
Where Ma represents Group A and Mb represents Group B of the study. 
The groups (n) were selected without bias in both categories. A group of 274 patients were 
contacted of which 79 patients responded to the survey. This group of 79 participants was 
used for the study. This resulted in 39 participants representing group A and 40 participants 
representing Group B.  
Patients‘ responses to the survey questions were compared first between the two groups and 
secondly compared to other studies.    
 
3.6 Data collection methods 
The electronic survey was sent to patients from whom an e-mail address had been collected. 
The questions were formulated according to a model established during the literature study. 
The questionnaire comprised of dichotomous questions, multiple-choice questions and open-
ended questions. Participants were expected to self-report on whether they have finished their 
antibiotic course or how much of the course was left-over. They were asked to report on their 
knowledge of antibiotics before and after they have read the information leaflet and the 
influence that will have on future antibiotic use. Participants also reported on possible reasons 
for non-compliance. 
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The questionnaire focused on the different levels of knowledge of antibiotics resistance 
development between the groups 
All patient responses during the study period were entered into a data collection file. This file 
was constructed in Microsoft Office Word 2003. The file contained the following 
information: 
 A unique subject number assigned to each patient who responded to the 
electronic survey. 
 The patient prescription without patient details together with the participant‘s 
response was copied into the collection file under each assigned subject number.  
The subject number was used to represent the patient in order to maintain patient 
confidentiality. Only the researcher had access to the patient‘s details. 
The copy of the patient‘s prescription with the corresponding subject number was used to 
collect more of the patient‘s personal information. Hospital discharge prescriptions have 
patient details on, or the retail pharmacy system (UNISOLVE) contains such details. These 
systems were reviewed to determine patient gender and age. 
The e-mail consisted of a cover letter and a questionnaire.  
The cover letter explained that the response to the questionnaire would be used for research. 
The patient was assured of patient confidentiality and that consent to partake in the study 
would be given by responding to the electronic survey. 
The questionnaire collected the following information: 
 Whether the patient completed the antibiotic course. 
 Whether the antibiotic course was completed in the prescribed time frame. 
 Possible causes there might be for non-compliance. 
 Whether the patient knows why he/she should complete an antibiotic course. 
 What the patient do with left-over antibiotics. 
 Patient views on common colds, flu and antibiotic use. 
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 Whether the patient received a brochure on antibiotic use and whether the patient read 
the brochure. 
 What did the patient learn by reading the brochure? 
 Would the patient prefer to receive more information on antibiotic use from their 
pharmacist? 
A data sheet was designed in Microsoft Office Excel 2003, consolidating the information 
collected for each subject in the same format as the electronic survey. The data sheet 
contained data collected from Group A separate from Group B. 
 
3.7 Data analysis  
All collected data were analysed in a very simple form. The data were sorted into two groups, 
representing Group A and Group B. Responses for the two groups were compared.  
Open-ended question responses that were similar were group together, to be compared to 
other responses.   
 
3.8 Ethical considerations 
An application for approval to conduct the study was submitted for review and was granted 
by the Human Research Ethics Committee at the University of the Witwatersrand (Annexure 
C). 
Approval from Pretoria East Hospital Pharmacy for collection of data were obtained 
(Annexure D). 
Consent was given by each participant for the information to be used in a research study, by 
responding to the electronic survey. They were informed that the data collected would be used 
for research and that their information would be kept confidential. 
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Chapter 4: Results and discussion  
4.1 Patient population 
A total of 274 patients were contacted in connection with the study via e-mail. All of these 
patients received antibiotics from the study site and provided the pharmacy with an e-mail 
address. 
Figure 4.1: Participant response rate 
 
274 
Patients  
138 
Received additional 
antibiotic 
information 
136 
Received no 
additional antibiotic 
information 
 
39 responses 
= 
39 participants 
 
99 no response 
40 responses  
= 
40 participants 
 
96 no response  
32 read the 
additional 
information  
= 
Group Aa 
 
7 did not read the 
additional 
information 
= 
Group Ab 
40 did not receive 
additional 
information  
= 
Group B 
 
24 adult participants 
8 child participants 
 
4 adult participants 
3 child participants 
 
31 adult participants 
9 child participants 
71 adult patients 
28 child patients 
71 adult patients 
25 child patients 
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Figure 4.1 shows the total amount of patients contacted during the study with a final 79 
participants that made up the study population. The electronic survey study had a response 
rate of 28.83%. 
In well-educated populations, response rates can vary from as low as 3% up to 90%. As a rule 
of thumb, the best response levels are achieved from highly-educated people and people with 
a particular interest in the subject. According to Sheehan (2001), e-mail response rates may 
only approximate 25% to 30% without a follow-up e-mail or reinforcements. In this study 
only 79 out of 273 patients responded to the electronic survey. The response rate of 28.83% 
correlates well with Sheehan‘s findings.  
The main objective of this study was to determine whether a better understanding of 
resistance formation and patient education improved patient compliance in antibiotic use. 
Patient antibiotic compliance was investigated as well as reasons for non-compliance. Results 
from this study were compared to previous studies done globally.  
Adult patients were divided into gender groups. More female patients were approached for the 
study. More female patients than male patients participated in the study by responding to the 
survey. A similarly higher percentage of female patients compared to male patients did also 
not respond to the survey. 
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Figure 4.2: Gender distribution among adult patients 
The group of 79 participants who responded to the survey consisted of 25 (31.64%) males, 34 
(43.03%) females and 20 (25.32%) children. Group A, who received additional antibiotic 
information, was represented by 39 participants, making up 49.37% of the study population. 
Group B, who received no additional antibiotic information, had 40 participants with 50.63% 
of the study population.  
 
Adult 
patients 
N=200 
Females 
56% 
Males 44%  
Patient received 
additional 
information and 
responded to 
survey 
Patient received 
additional 
information and  
did not respond 
to survey 
 
Patient received  
no additional 
information and 
responded to 
survey 
 
Patient received 
no additional 
information and  
did not respond 
to survey 
 
Group Aa 
 
Female 58.33% 
Male 41.66% 
 
Female 56.34% 
     Male 43.66% 
Group B 
 
Female 58.06% 
Male 41.94% 
 
Female 52.11% 
Male 47.89% 
 
Group Ab 
 
Female 50% 
Male 50% 
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Figure 4.3 Patient age distribution  
Considering all patients contacted in connection with the research study, 27% was represented 
by prescriptions for children (up to 14 years of age) and 73% by prescriptions for adults.  
50.36% of the whole patient group consisted of patients aged between 20 and 59 years. The 
age group distribution is presented in Figure 4.3. 
Patients who received an information leaflet and responded to the study formed Group A of 
the study group. Considering only adult prescriptions, in Group A only female patients 
between the ages 15 to 29 years responded to the survey. A higher percentage of females in 
the age group 50-59 years responded the survey than male patients in this age group. Male 
patients between the ages of 30 and 39 years yielded a higher response rate than female 
patients. Child prescriptions will be dwelt with at a later stage. 
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The patient response per age group and gender, who received the antibiotic leaflet, is 
demonstrated in Figure 4.4. 
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Figure 4.4 The percentage of responding patients per age group and gender who 
received the antibiotic leaflet. Group A: N = 39 
The patient group who did not receive an antibiotic leaflet but responded to the survey 
formed Group B of the study group. A considerably higher percentage of male patients aged 
15 to 19 years responded to the survey compared to Group A. Only female patients aged 20-
29 years responded to the survey and formed part of the study group. Male as well as female 
patients aged 30-39 years responded well to the survey. Participants in the age group 40-49 
years demonstrated a similar response to that of Group A with a higher male response 
between 50 and 59 years in Group B who did not receive any additional reading material 
concerning antibiotic use.  
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Figure 4.5 demonstrates the percentage of responding patients per age group and gender who 
did not receive the antibiotic leaflet. 
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Figure 4.5 The percentage of responding patients per age group and gender who did 
not receive the antibiotic leaflet. Group B: N = 40 
In general the female patients showed a higher response to the survey than male patients. No 
male patients between the ages of 20 to 29 years showed any interest in the study. More male 
participants aged 50 to 59 years responded to the electronic survey without having to read a 
leaflet. 
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Table 4.1 Participant demographics 
Table 4.1 shows the subdivisions and demographics of the study group. The study population 
was divided into Group A and Group B, where Group A received a leaflet containing 
information on responsible antibiotic use and Group B received no additional antibiotic 
information. Group A was further subdivided into a group that read the leaflet and a group 
that did not read the leaflet representing Group Aa and Group Ab respectively. 
Study 
group 
Group A 
49.37% 
 Group B 
50.63% 
  
N = 79 
participants 
39 received 
a leaflet 
 40 received 
no leaflet  
Gender/ 
age 
% per 
gender/ age 
group 
 Group Aa 
82.05% 
Group Ab 
17.95% 
   
 32 read the 
leaflet 
7 didn‘t read 
the leaflet 
   
 9 male 2 male 13 male 25 male 31.64% 
 14 female 2 female 18 female 34 female 43.04% 
 8 children 3 children 9 children 20 children 25.32% 
100% 40.51% 8.86% 50.63%  100% 
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Figure 4.6 Demographic overview of participants  
 
4.2 Survey responses 
4.2.1 Participant antibiotic compliance 
Question Sample 
(N) 79 
Yes % No % Group 
total 
1. Have 
you 
finished 
your 
antibiotic 
course? 
Group 
Aa 
31 96.88% 1 3.12% 32 (100%) 
Group 
Ab 
5 71.43% 2 28.57% 7 (100%) 
Group B 34 85% 6 15% 40 (100%) 
Total 70 88.61% 9 11.39% 79 (100%) 
Table 4.2 Antibiotic compliance distribution 
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One can consider Group Ab and Group B together as neither read the leaflet containing 
information on why antibiotic compliance is important. This new group represented 90.91% 
of the non-compliant patients. 
The one patient in Group Aa that was non-compliant admitted to knowing that one should 
complete an antibiotic course in another part of the survey. The non-compliant group 
consisted of eight adults and one child with 88.88% represented by adults and 11.11% by 
children. 
Question Sample 
(N) 79 
Yes % No % Group 
total 
2. Did you 
complete 
the 
antibiotics 
in the 
prescribed 
time? 
 
Group 
Aa 
30 93.75% 2 6.25% 32 (100%) 
Group 
Ab 
5 71.43% 2 28.87% 7 (100%) 
Group B 33 82.50% 7 17.50% 40 (100%) 
Total 68 86.08% 11 13.92% 79 (100%) 
Table 4.3 Antibiotic compliance related to prescribed course periods 
All non-compliant participants included participants who did not complete their antibiotic 
courses at all. Considering Group Ab and Group B together, as neither of these groups read 
the additional information nor received the information, they represent 81.81% of the non-
compliant population. Eleven participants (10 adult and one paediatric prescription) were not 
compliant. The adult non-compliant group consisted of 70 % female participants and 30% 
male participants. 
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Although there is much controversy in the literature regarding gender and compliance, some 
studies reported that gender was no significant predictor of compliance (Kane & Shaya, 
2007). In this study gender groups responded differently depending on the age group. 
On a self -pill-count, 86.08% of all the participants reported that they have been compliant to 
the antibiotic prescription and 13.92% admitted that they were non-compliant. 
Participants from Group Ab and Group B accounted for 90.91% of the non-compliant 
participant group with ten participants from these two groups not completing their courses 
and only one participant from group Aa. There has been a significant difference between the 
participants who read the additional antibiotic information and the groups who did not.  
The same results were evident with an investigation into the antibiotic compliance when 
considering the time period of the antibiotic prescription where patients had to complete an 
antibiotic course within a specific period of time. 
 In a 1999 United Kingdom survey, 38% of respondents did not know that antibiotics do not 
work against most coughs or colds, 11.3% reported that they did not finish their last antibiotic 
course as prescribed. When asked why they did not finish the course, 65% reported  that it was 
because they felt better or forgot to take them. Two per cent did not start the course at all,  and 
the same percentage reported that the antibiotics did not work. 19% stopped them because of 
side effects (McNulty et al.2007).  
Compliance decreased with increased complexity of regimen and was 79% ± 14% for once 
daily dosing, 69% ± 15% for twice daily dosing, decreasing even more with three times daily 
dosing and four times a day dosing (Claxtont et al. 2001). Compliance depends also on the 
length of treatment. Better compliance was observed for regimens shorter than 7 days duration 
compared with longer ones (Kardas 2002).  
Participants were asked to give reasons for stopping with their antibiotic courses before they 
have completed the course. Their responses are illustrated in Figure 4.7: 
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19%
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antibiotic course was finished
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wose
The antibiotic course was too long
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antibiotics because of tablet size or
flavour
The patient forgot to take the
antibiotic
Other reasons
 Figure 4.7 Reported reasons for patient non-compliance by non-compliant participants 
Question 3: The following might be possible reasons for not finishing the 
prescribed antibiotics. Choose the most appropriate option. 
Reason        Result        Persentage 
You felt better before the antibiotic course was finished  5          31% 
The antibiotics made you feel worse     1          6% 
The antibiotic course was too long     3         19% 
You did not know for how long to take your antibiotics   0          0% 
You did not receive the whole antibiotic course    0          0% 
You had trouble taking the antibiotics because of tablet size/flavour 1          6% 
You forgot to take the antibiotic      3         19% 
Other reasons or when answering Yes to question 1.   3         19%  
N = 16                   100% 
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The largest portion (31%) of non- compliant participants did not complete the course because 
they felt better before the end of the course. An equal number of participants said that the 
course was either too long (19%), they forgot to take the antibiotic (19%) or had other reasons 
(19%) for not completing the course. 
Branthwaite & Pechère (1996) reported that interviewees were positive about antibiotics, with 
over 75% judging them to be effective and to speed recovery. Over 80% of respondents 
expected symptoms to improve after 3 days' treatment. This provided a natural watershed for 
compliance, with most defaulters stopping after 3 days because they felt better. 
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4.2.2 Participant knowledge on antibiotic resistance 
Question 4: Do you know what happens when one does not finish a course of antibiotics?            
What do you think will happen? 
 Figure 4.8 Participant knowledge regarding antibiotic resistance  
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Participants‘ responses to the question regarding their knowledge on why an antibiotic course 
should be completed were grouped into similar themes to form five main statements. Another 
group who admitted knowing that one should complete the course of antibiotics but gave no 
reason as to why this is the case, formed the sixth statement.  
27%19%
24% 23%
1%
6%
Do not know
Antibiotic will stop working
Resistance develop
Infection will not clear
No Answer
Patient becomes immune
 
Figure 4.9 Reported reasons for completing antibiotic courses  
All participants who did not know the reason for completing antibiotic courses consisted of 
Group Ab and Group B. Thus 100% of these participants did not receive additional 
information on responsible antibiotic use. 
The participants who gave reasons for completing antibiotic courses consisted of 55.17% 
represented by Group Aa, 6.90% Group Ab and 37.93% Group B. 
Group Aa responded 100% positively. Only 55% of Group B responded positively and 
57.14% of Group Ab. 
The greatest percentage of participants that knew that one should complete the course of 
antibiotics to prevent resistance of bacteria to antibiotics, were from Group Aa.   
 - 41 - 
On testing participants‘ knowledge of antibiotic resistance, 26.58% (21 participants) did not 
know why they need to complete an antibiotic course. This entire group consisted of Group 
Ab and Group B who either did not receive additional information on antibiotics or did not 
read the brochure. On the other hand 73.42% gave reasons for completing antibiotic courses 
with the majority represented by Group Aa who read the additional antibiotic information. 
 
4.2.3 Participant attitude toward antibiotics 
4.2.3.1 Left-over antibiotics 
Participants reported on what they would have done with left-over antibiotics in the past and 
how they would handle left-over antibiotics in the future based on their new knowledge of 
antibiotics received in the form of the leaflet. 
Question 5: What have you done with left-over antibiotics in the past? 
Kept it for future use 
Threw it away 
Gave it to someone that needed antibiotics 
Question 6: What would you do with left-over antibiotics in future? 
All of the19 participants in Figure 4.10 used to keep antibiotics for future use. Twenty four 
percent of all the participants formed part of this group. Participants from Group Aa who read 
the leaflet on responsible antibiotic use showed a 77.78% positive change by committing to 
completing antibiotic courses in future.  
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Figure 4.10 Participants kept left-over antibiotics for future use 
In the United Kingdom almost 16% reported that they have kept an antibiotic in the past; 31% 
reported that they needed them again and 8% of case the same infection recurred. Respondents 
who reported keeping left-over antibiotics tended to be younger (McNulty et al. 2007).   
Some participants used to throw away unused antibiotics. Their responses are demonstrated in 
Figure 4.11.   
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Figure 4.11 Participants threw away left-over antibiotics  
A large portion of the participant population threw away left-over antibiotics in the past. A 
total of 62.03% of the study population admitted to this behaviour. Nearly 70% of Group Aa 
who used to throw away left-over antibiotics, committed to completing their antibiotic 
courses in future.  
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A small portion (3.8%) of the participants used to keep unused antibiotics for someone else 
who might need it.  
 
 
Figure 4.12 Participants gave left-over antibiotics to someone in need of antibiotics 
All participants represented in Figure 4.12 showed a 100% improved behaviour concerning 
antibiotic use. 
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Although participants only had three options to choose from in the survey question 
concerning past and future antibiotic use behaviours, 10 participants chose to add another 
answer by stating that they always complete antibiotic courses. The distribution of 
participants is shown in Figure 4.13. 
 
Figure 4.13 Participants always complete an antibiotic course 
In conclusion, approximately 78% of Group Aa who used to keep left-over antibiotics for 
future use will in future complete the course. Nearly 71% of Group Aa who threw away left-
over antibiotics will in future complete the course and 100% of Group Aa who kept 
antibiotics for someone who might need it, will complete the course in future. This shows a 
84.38% positive change in Group Aa. 
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4.2.3.2 Pressuring doctors for antibiotic prescriptions 
As part of the survey, participants were tested on their knowledge of antibiotic use in viral 
infections.  
Question 7: Would you ask your doctor for antibiotics when you have a common cold? 
Yes  
No  
Have you asked your doctor for antibiotics when having a common cold in the past? 
73% of the study population had never put pressure on a medical practitioner to prescribe 
antibiotics in a viral infection. Group Aa showed a 31.25% improvement in participant 
behaviour with 100% of the group intending not using antibiotics in viral infections in future. 
N=79 Group  Past % Future % 
 Group Aa 22/32 68.75% 32/32 100% 
 Group Ab 4/7 57.14% 4/7 57.14% 
 Group B 32/40 80% 32/40 80% 
Table 4.4 Participants who do not put pressure on doctors to prescribe antibiotics in 
viral infections  
Thirty one percent of Group Aa admitted to pressuring health professionals in the past to 
supply antibiotics. None of Group Aa will pressure doctors unnecessarily for antibiotics in 
future, with a 100% positive change in attitude and no change in Group Ab and Group B. 
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Figure 4.14 Pressure from participants to get antibiotics prescriptions for viral 
infections 
In a global survey, pressure on general practitioners to prescribe antibiotics was highlighted 
by over 50% of interviewees' believing that they should be prescribed for most respiratory 
tract infections. Interviewees were positive about antibiotics, with over 75% judging them to 
be effective and to speed recovery. Over 80% of respondents expected symptoms to improve 
after 3 days' treatment. This provided a natural watershed for compliance, with most 
defaulters stopping after 3 days because they felt better. (Branthwaite & Pechère 1996).  
 
4.2.3.3 Participants’ willingness to change their attitude towards 
antibiotic use 
Participants were asked to comment on how they might change their behaviour when taking 
antibiotics in future. Only participants from Group Aa who read the leaflet handed to them, 
commented. The comments that implicated the same idea were grouped in into statements. 
Question 8: In what way would you change your use of antibiotics, if you would change 
anything? 
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N =32  Statement # Statement  
15 Nr. 1 Nothing Participants did complete course 
in prescribed time and have not 
asked for antibiotics from a 
medical practitioner 
10 Nr. 2 One should always complete 
the course 
(1 overlap statement Nr 4 and 1 
overlap with Nr 5) 
2 Nr. 3 One should only use 
antibiotics when it is necessary 
 
4 Nr. 4 One should use antibiotics for 
bacterial infections and not for 
viral infections  
(1 overlap statement Nr 2) 
2 Nr. 5 One should not pressure a 
medical practitioner for an 
antibiotic prescription when 
having a flu  
(1 overlap with statement Nr 2) 
1   No answer provided 
Table 4.5 Participants changes to future antibiotic use 
Participants who already showed responsible use of antibiotics chose statement Nr 1, with no 
changes needed in their antibiotic use. 56.25% of participants in Group Aa gained knowledge 
and based on that will use antibiotics more responsible in future. 
The leaflet was supplied to patients as a tool to enrich their knowledge on responsible 
antibiotic use. Participants were asked to give feedback on what they have learned by reading 
the leaflet. Only the participants form Group Aa commented. The comments that implicated 
the same idea were grouped in into statements. 
87.50% of Group Aa learned something by reading the leaflet concerning responsible 
antibiotic use. 9.38% of Group Aa did not learn anything new and one participant chose the 
incorrect statement Nr 5. 
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Question 10: What is the most important lesson you learned by reading the 'Antibiotics: 
wise-up and take responsibility' brochure? 
N =32  Statement # Statement  
12 Nr. 1 Antibiotics has no effect on 
viruses and should only be 
used for bacterial infections, 
not colds and flu 
(1overlap with statement Nr 2) 
12 Nr. 2 All bacteria need to be killed 
by the antibiotic and the course 
should be completed to reduce 
antibiotic resistance  
(1overlap with statement Nr 1) 
(2overlap with statement Nr 3) 
7 Nr. 3 One should not over use 
antibiotics   
(2 overlap with statement Nr 2) 
3 Nr. 4 Nothing learned  
1 Nr. 5 Patients will become immune 
to antibiotics 
 
Table 4.6 Lessons learned by Group Aa. 
Participants from Group Aa commented on the knowledge that they have gained from the 
leaflet handed to them. Participants who already showed responsible use of antibiotics chose 
not to change anything about the way they use antibiotics. Nearly 88 % of participants in 
Group Aa gained knowledge on not to use antibiotics for viral infections, to complete the 
course and not to over use antibiotics and based on that will use antibiotics more responsible 
in future. 
McNulty (2007) found that four years after the campaign on antibiotic use in the United 
Kingdom in 1999 only a fifth of respondents and only 25% of respondents who had been 
prescribed an antibiotic in the past year, had seen or heard of the campaign. A third of the 
public still believe that antibiotics work against coughs and colds, and it has been shown that 
those with a greater knowledge about antibiotics are no less likely to be prescribed an 
antibiotic. And in respect of how the public use the antibiotics they are prescribed, sometimes 
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increased knowledge is associated with more prudent use or higher chances to self-medicate. 
Greater knowledge about antibiotics was associated with a greater tendency to keep left-over 
antibiotics and use them without advice from a clinician (McNulty et al.2007).  
Participants in this study responded to the survey within a week or two after they have read 
the leaflet. The information was still fresh in their memory but one could conclude from 
McNulty‘s study that patients will need constant reminders as to how they should use 
antibiotics responsibly. 
4.2.3.4 Participant willingness to learn more about responsible antibiotic use 
Question 11: Would you prefer to receive more information on responsible antibiotic 
use? 
Table 4.7 demonstrates the various responses by different groups on their willingness to learn 
more on how to responsibly use antibiotics 
Answer Group  Gender/Age Group 
  Female Male Children 
Yes Group Aa 12 7 7 
Group Ab 1 1 3 
Group B 11 8 4 
Total: 54       
(68.35%) 
 Total: 24 
(70.59%) 
Total: 16   
(64%) 
Total: 14   
(70%) 
No Group Aa 2 3 1 
Group Ab 1 1 0 
Group B 7 5 5 
Total: 25       
(31.64%) 
 Total: 10 
(29.41%) 
Total: 9       
(36%) 
Total: 6     
(30%) 
Total: 100%  100% 100% 100% 
Table 4.7 Participants’ willingness to learn more about responsible antibiotic use  
 - 51 - 
Participants from Group Aa showed most willingness to learn more about antibiotic use with 
females and children making out the largest portion of the group. Male participants tended to 
be less eager to learn more about responsible antibiotic use. Eighty one persent of Group Aa 
showed a willingness to learn more about antibiotics. Only 57.50% of Group B showed 
interest in learning more about responsible antibiotic use. 
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Figure 4.15 Overview on participants’ willingness to learn more about responsible 
antibiotic use 
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4.3 Child prescription responses 
Child prescriptions formed part of the study population. Parents or guardians of these children 
responded to the survey. The group that received leaflets with their medication had a 28.21% 
response rate and the group without leaflets had a 28.57% response rate. There is therefore no 
significant difference between the 2 groups.  
Figure 4.16 shows the number of responding child patients compared to the non-responding 
child patients.  
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Figure 4.16 Proportion of participating child participants compared to non-responders 
Figure 4.15 showed that 70% of adults responding on behalf of a child would prefer to receive 
additional information regarding antibiotic use from their pharmacist. 
Child participants showed 95% antibiotic compliance. It is thought that these children showed 
a high compliance rate because of an adult giving their medication according to the 
prescriber‘s orders. Parents are often more concerned about a small child‘s health than their 
own and might explain why they follow the doctor‘s orders to the letter. 
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Chapter 5: Recommendations 
Future campaigns that are aimed at reducing the level of prescribing antibiotics unnecessarily 
should be focused towards those more likely to be prescribed an antibiotic. In this study 
women aged between 20 and 50 years as well as child prescriptions made out a large portion 
of the study group.  
We should examine and consider modifying consultation behaviours of prescribers and other 
behavioural components involved in patients expectations for antibiotics. This should include 
delayed antibiotic prescriptions. 
We could focus the message that antibiotics should be completed and not stored for future use 
towards the higher educated, young women who are more likely to store and take antibiotics 
without advice. 
Some reports recommend that the public should be educated about the value of their normal 
flora. Normal flora did not feature in this survey although various participants indicated that 
they would prefer more information on probiotic use together with antibiotics. In the McNulty 
(2007) study, 42% of respondents did not agree with the statement ‗Bacteria that normally live 
on the skin and in the gut are good for your health‘ and 43% of respondents did not agree that 
‗Antibiotics can kill bacteria that normally live on the skin and gut‘. 
Campaigns on the responsible use of antibiotics need to become a everyday practice for all 
health practitioners. Experience with social marketing for other health issues such as alcohol 
and driving shows that campaigns must be sustained over several years and have to be 
highlighted continuously. 
More campaigns can be run in South Africa to emphasize responsible antibiotic use, focusing 
on healthcare professionals and the public. Campaigns to fight antibiotic resistance should be 
supported by government and be institutionalised by the Minister of Health. There are two 
suggestions: First, education and awareness of this issue must increase among the medical 
community. Second, political, and scientific forces must work together to recognize the scope 
of the problem and develop solutions. 
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Strategies to address antimicrobial resistance should be introduced that would strengthen 
antimicrobial resistance surveillance, help with prevention and control, and research efforts, 
and it should enhance the collection of critical information on the use of antibiotics in humans 
and animals.  
Many private hospitals focus on antibiotic stewardship programmes with in-patients. 
Extending this practice to out-patients as well could have a huge effect on the way 
practitioners write antibiotic prescriptions for patients with less severe infections. 
Pharmacists play a very important role in educating the patient, and should use the 
opportunity to give out-patients proper advice and information regarding the use of 
antibiotics. Pharmacists could explain to the patient why it is important to complete the 
antibiotic course or hand out information to patients regarding responsible antibiotic use.  
When non-compliance is recognised, the pharmacist is in a good position to offer support to 
the patient. The approach should be to attempt to remove obvious barriers to compliance. A 
concordant approach should be adopted. However, for the pharmacist to provide advice that is 
consistent with the treatment-plan of the physician, pharmacists should be recognised as part 
of the healthcare team and be involved in the treatment-plan of a patient. Depending on the 
nature of the problem, counselling by the pharmacist may assist in improving compliance. 
Many studies suggest that the easiest way to reduce the use of left-over antibiotics and 
improve compliance is to shorten the course of antibiotics prescribed to 3 or 5 days. Female 
patient compliance might be increased by focussing on shorter courses or fewer dosage 
intervals. 
It is necessary to create a changed mindset in clinicians‘ and patients' beliefs about the 
expectations for and effectiveness of antibiotics for minor illness, to be able to control and 
decrease the unnecessary use of antibiotics (McNulty et al. 2007).    
Turnidge (1998) wrote that it is generally agreed that the best way to reduce the selective 
pressure of antibiotics is to reduce usage. Australia and Hungary have shown that this is 
possible, but finding effective ways to do this is not simple. A coordinated cooperative effort 
between the professionals, patients, and regulators is required. The elements of this 
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coordinated approach include education, regulatory measures, public health measures, 
surveillance, and further research. 
Education of both professionals and the public is a key component to change. There have 
been many efforts over the years to improve rational use of antibiotics though education. 
Techniques such as the development of consensus guidelines; promotion of rational 
prescribing methods, including better use of diagnostics; promotion of shorter treatment 
courses where these have been shown to be equally effective; and the use of delayed 
prescribing (prescription is written but filled only if the condition worsens) have been used 
extensively. Additional techniques—such as rotational usage in an individual patient or in a 
practice, the use of different antibiotic classes in different conditions to spread selective 
pressure, and a stronger emphasis on narrow spectrum agents—need to be considered. None 
of these techniques will be effective, however, until the public becomes better educated about 
infectious diseases and the role of antibiotics, including such simple distinctions as the 
difference between viruses and bacteria. Ideally, this should start in secondary school as part 
of health education and biology courses. Patients should also be educated at the time of 
consultation, and the message that antibiotics are not useful in many common infections 
should be reinforced. Brochures and other educational material handed out at the time of 
consultation can help in this process. The risks of prescribing antibiotics when they are not 
needed must be emphasised, such as the side effects and potential for picking up resistant 
organisms and spreading them to others. This ―green‖ message will be easier to sell now that 
the public is more aware of personal health and environmental issues. When antibiotics are 
prescribed, increased attention must be given to ensuring compliance and patients‘ 
understanding through such instruments as consumer product information leaflets (Turnidge 
1998). 
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Chapter 6: Limitations 
Various areas of the study could be seen as limitations to the study results. 
The questionnaire was only completed by patients with access to e-mail. This group of 
participants were from one pharmacy in the private sector only. Although the hospital service 
patients from all backgrounds, the majority of patients might be seen as educated and from a 
higher income group. This should not influence the study results as the focus of the study is 
on the influence of extra information on antibiotic use and not on the influence of different 
backgrounds of patients on antibiotic use.  
Pharmacists who had to give out the leaflet concerning the responsible use of antibiotics, had 
to do so without bias but work under pressure and often forgot to give out leaflets or gave it to 
more approachable customers. 
Participants often give information that they think might be acceptable to the researcher.  
Child prescriptions that formed part of the study had an adult responding on behalf of the 
child. The child prescription group was still kept segregated from the adult group to test for 
any difference in compliance between the groups. 
Non-response bias due to a low response rate of 29% affects both the reliability and validity 
of survey study findings.  
Fincham (2008) found that e-mail surveys incorporating multimode approaches may yield 
response rates as high as 70%. Allowing for differing methods of returning surveys (e-mail 
and/or mailed options; eg, multimode) will aid those respondents who prefer to print out a 
survey instrument and respond via mail. This mixed-mode approach, combining both mailed 
and e-mailed survey instruments with an Internet-based response mechanism, also is an 
approach to help reduce the problem of coverage error in administration of surveys.  
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Chapter 7: Conclusion.  
The main objective of the study was to determine whether a better understanding of 
responsible antibiotic use will lead to better compliance. The hypothesis H = Ma > Mb, where 
Ma represents Group A and Mb represents Group B of the study, proved to be true. The 
hypothesis state that Group A (Ma) will be more influenced by the additional antibiotic 
information than Group B (Mb). 
Group Aa showed a better compliance to the antibiotic regimen prescribed. When compared 
to Group Ab and Group B, a much higher percentage of this group was able to give valid 
reasons as to why one should complete an antibiotic course. 
78% of Group Aa intended to change their future behaviour with regards to left-over 
antibiotics. These patients are committed to being completely compliant in future. This group 
showed a 100% change in attitude when it comes to pressurizing medical practitioners into 
prescribing antibiotics for minor illness, colds and flu. 
The majority of Group Aa admitted to learning something by reading the leaflet handed to 
them and also showed most interest in wanting more antibiotic information from their 
pharmacist in future. 
Participants gave various reasons for not being compliant. Most patients stopped taking their 
antibiotics as soon as they felt better.  
Participants from Group Aa showed most willingness to learn more about antibiotic use with 
females and children making out the largest portion of the group. Male participants tended to 
be less eager to learn more about responsible antibiotic use. 
The child group that received leaflets with their medication had a 28.21% response rate and 
the group without leaflets had a 28.57% response rate. There is therefore no significant 
difference between the 2 groups. 
The study suggests that handing out information leaflets has an effect on patients‘ 
understanding of antibiotic resistance and compliance. This might not be the case for all age 
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groups, for instance, young adult males. This age group might need another approach. Male 
patients in their middle-ages also showed response to the e-mail; but not very good response 
to the leaflet handed to them. This age group might be reached by sending antibiotic 
information by e-mail and not handed out to them.  
It is my conclusion that the additional information given to patients at the pharmacy level can 
make a great impact in the patient‘s view of when and how antibiotics should be used.  
 
 
 
 
 
 
 
 
 
 
 
 
 - 59 - 
References 
Arnold, SR & Straus, SE 2005 ‗Interventions to improve antibiotic prescribing practices in 
ambulatory care‘, Cochrane Database Syst Rev . Retrieved July 25, 2010, from 
http://www.ncbi.nlm.nih.gov/pubmed/16235325  
Bell, SJ, Airakinen, MS, Lyles, A, Chen, TF, Aslani, P, 2007, Concordance is not synonomous 
with compliance or adherence, British Journal of Clinical Pharmacology, vol. 64, no. 5, pp. 
710-711. 
Branthwaite, A & Pechère, JC 1996, ‗Pan-European survey of patients‘ attitudes to  antibiotics 
and antibiotic use‘, Journal of International Medical Research, Vol. 24,   no 6, pp229-238. 
Retrieved January 19, 2009, from http://www.ncbi.nih.gov/pubmed 
Brown, J & Goff, DA 2005, ‗Shorter-course Antibiotic Therapy for CARTIs: Is shorter 
better?‘, Pharmacy Times. Retrieved January 19, 2009, from 
http://secure.pharmacytimes.com/lessons/200510-02.asp# 
Claxton, AJ, Cramer, J & Pierce, C 2001, ‗A systematic review of the association between 
dose regimens and medication compliance‘, Clinical Therapeutics, vol. 23, pp.1296–310. 
Cockburn, J, Gibberd, RW, Reid, AL & Sanson-Fisher, RW 1987, ‘Determinants of non-
compliance with short-term antibiotic regimens‘, British Medical Journal , vol. 295, pp. 814-
818. 
Cook, RC, Zachariah, J, Cree, F & Harrison, HE 1996, ‗Efficacy of twice-daily 
amoxicillin\clavulanic acid (‗Augmentin-Duo 400\75‘) in mild to moderate respirtory tract 
infections in children, British Journal of Clinical Practice, Vol 50, pp. 125-128. 
Cowen, LE 2008, "The evolution of fungal drug resistance: modulating the trajectory from 
genotype to phenotype", Naure Reviews. Microbiology, vol.  6, no. 3, pp. 187–98.  
Creative Research Systems n.d., Survey Design- How to Begin your Survey Design  Project. 
Retrieved January 27, 2009, from http://www.surveysystem.com/sdesign.htm 
 - 60 - 
Ellerbeck, E, Khallaf, N, el Ansary, KS, Moursi, S & Black, R 1995, ‗Caretaker compliance 
with different antibiotic formulations for treatment of childhood pneumonia‘, Journal of 
Tropical Pediatrics, vol. 41, pp. 102–108. 
Favre, O, Delacretaz, E, Badan, M, Glauser, M & Waeber, B 1997, ‗Relationship between the 
prescriber‘s instructions and compliance with antibiotherapy in outpatients treated for an 
acute infectious disease‘, Journal of Clinical Pharmacology, vol. 37, pp.175–178. 
Fincham, JE 2007, Patient compliance with medications: Issues and opportunities, 
Pharmaceutical Products Press, Binghamton, New York 
Fincham, JE 2008, ‗Response Rates and Responsiveness for Surveys, Standards, and 
the Journal’, American Journal of Pharmaceutical Education, vol. 72, no. 2, p.43 
Jackson, C, Lawton, RJ, Raynor, DK, Knapp, P, Conner, MT, Lowe, CL, Closs, SJ 2006, 
‗Promoting adherence to antibiotics: A test of implementation intentions‘, Patient Education 
and Counselling, Vol. 61, Issue 1, pp 212-218. 
Kane, S, Shaya, F 2007, ‗Medication non-adherence is associated with increased medical 
health care costs‘, Digestive disease and Science, Vol. 53, Issue 4, pp. 1020–1024. 
Kardas, P 2002, Patient compliance with antibiotics in respiratory tract infections, Journal of 
Antimicrobial Chemotherapy, Vol. 49, Issue 6, pp. 897-903. 
Levy, SB 1994, ‗Balancing the drug-resistance equation‘,Trends Microbiology, vol. 2, no.10, 
pp. 341–2.  
McNulty, CAM, Boyle, P, Nicolas, T, Clappison, P & Davey, P 2007, ‗The Public‘s Attitudes 
to and compliance with antibiotics‘, Journal of Antimicrobial  Chemotherapy, Vol. 60, 
Supplement 1, pp63-68. Retrieved January 19, 2009, from http://jac.oxfordjournals.org 
Murphy, A 2007, Asthma in Focus, Pharmaceutical Press, Greyslake, USA. 
Noreddin, A n.d., Bacterial Resistance: Overview and Implications for Clinical Practice. 
Retreived July 14, 2010, from http://www.rpi.edu/~angel/LOURDES/bacterialresistance.pdf 
 - 61 - 
Pearson, C 2007, ‗Antibiotic Resistance Fast-Growing Problem Worldwide‘. Voice of 
America. Retrieved November 29, 2010, from  
http://en.wikipedia.org/wiki/Wikipedia:Link_rot 
Reyes, H, Guiscafre, H, Munoz, O, Perez-Cuevaz, R, Martinez, H & Guitierrez, G, 1997, 
‗Antibiotic non-compliance and waiste in upper respiratory infections and acute diarrhea‘, 
Journal of Clinical Epidemiology, vol.50, pp. 1297-1304. 
Schrag, SJ, Pena, C, Fernandez, J, Sanchez, J, Gomez, V & Perez, E 2001, ‗Effect of short-
course, high-dose amoxyxillin therapy on resistant pneumococcal carriage: a randomized 
trial‘, Journal of American Medical Association, vol.286, pp.1334-1338. 
Sheehan, K 2001, ‗E-mail survey response rates: a review‘, J Compu-Mediated Com. 
Retrieved September 20, 2010, from http://jcmc.indiana.edu/vol6/issue2/sheehan.html 
Statistics Canada n.d., Questionnaire Design. Retrieved January 27, 2009, from   
http://www.statcon.gc.ca/edu/power-pouvior/ch2/questionnaires/5214775-eng.htm 
Stokowski, LA 2010, ‗A Miracle of Medicine‘, Emerging Antibiotics: Will We Have What 
We Need?, Medscape Infectious Diseases. Retrieved November 4, 2010, from 
http://www.medscape.com/viewarticle/715971 
Todar, K 2004, ‘The Good, the Bad, and the Deadly’, Todar's Online Textbook of 
Bacteriology, Vol 304, p. 1421. Retrieved  August 14, 2010, from 
http://www.textbookofbacteriology.net/ 
Turnidge, J 1998, ‗What is to be done about resistance of antibiotics?‘, British Medical 
Journal, vol. 317, no. 7159, pp. 645-647. 
 
 
 
 - 62 - 
Appendix A 
Dear Pretoria East Hospital Pharmacy Patient, 
  
We would like to follow-up on the use of your antibiotics received at our pharmacy on 
________. A questionnaire survey has been compiled to measure patients‘ adherence to 
antibiotic prescription instructions and also the information received from the pharmacist or 
assistant that issued your prescribed antibiotics. 
  
We would appreciate it if you could take 3 minutes to answer the 11 questions. This survey 
aims to determine how we can improve our service to patients and ensure that patients receive 
the necessary information regarding the medication they need to take. 
  
All patient information will be kept confidential and will only be used for the purposes of the 
study. No names are asked in this questionnaire and all data will be saved anonymously. 
  
Your consent to partake in this study will be given by completing the questionnaire below and 
returning it to the sender. Your participation would be greatly appreciated. 
  
Please first answer the questions, next 'copy' the text with the given answers. Click on the 
‗reply‘ button, then 'paste' the completed questionnaire before clicking on the ‗send‘ button. 
 
1. Have you finished you antibiotic course? 
Yes 
No 
If you answered 'No', please specify how many of the tablets or how much of the suspension 
do you have left over? 
 
2. Did you finish the antibiotics in the prescribed time? 
Yes 
No 
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3. The following might be possible reasons for not finishing the prescribed 
antibiotics. Choose the most appropriate option. 
You felt better before the antibiotic course was finished 
The antibiotics made you feel worse 
The antibiotic course was too long 
You did not know for how long to take your antibiotics 
You did not receive the whole antibiotic course 
You had trouble taking the antibiotics because of tablet size or flavour 
You forgot to take the antibiotic 
Other reasons or when answering Yes to question 1. 
Please explain when choosing 'Other reasons': 
  
4. Do you know what happens when one does not finish a course of antibiotics? 
Yes 
No 
If your answer is 'Yes', what do you think would happen? 
  
5. What have you done with left-over antibiotics in the past? 
Kept it for future use 
Threw it away 
Gave it to someone that needed antibiotics 
6. What would you do with left-over antibiotics in future? 
  
7. Would you ask your doctor for antibiotics when you have a common cold? 
Yes 
No 
  
Have you asked your doctor for antibiotics when having a common cold in the past? 
 - 64 - 
8. Did you receive an 'Antibiotics: wise-up and take responsibility' brochure 
from your pharmacist? 
                                        Did you read the brochure? (answer from drop-down menu) 
Yes 
No 
  
 
    
9. What is the most important lesson you learned by reading the 'Antibiotics: 
wise-up and take responsibility' brochure? 
  
10. In what way would you change your use of antibiotics, if you would change 
anything? 
  
11. Would you prefer to receive more information on responsible antibiotic 
use? 
Yes 
No 
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Appendix B 
 
Antibiotics: Wise-up and take responsibility  
Antibiotics are the first line of defence against many infections, however, overusing or 
misusing antibiotics can cause treatment failure in future. 
What are antibiotics? 
Antibiotics are used for treating many less serious to life-threatening diseases caused by bacterial infections. Taking antibiotics when 
you don't need to, can lead to antibiotic-resistance. Antibiotics are only effective against bacterial infections, certain fungal infections and 
some kinds of parasites. Most infections result from either bacteria or viruses. Antibiotics are not effectiv e against v iral infections!        
Common bacterial infections cause severe upper-respiratory-tract infections e.g. pneumonia, wound and skin infections and urinary tract 
infections.                                                                                                                                                                                             
Common colds, influenza, most ear infections and stomach flu are caused by viral infections. These can be treated by anti-viral drugs or 
by treating the symptoms. 
                 
How does antibiotic resistance develop? 
Penicill in was introduced in the first part of the 20
th
 century and since then scientists have developed many more antibiotics to help stop 
the spread of infectious disease. Antibiotics have saved mill ions of l ives but because of frequent use, often for conditions or infec tions 
that aren't caused by bacteria, the bacteria have become resistant to many commonly used antibiotics.                                                                                                                                                              
Resistance develops when an antibiotic fails to kil l all of the bacteria it targets. The surviving bacteria adapt and beco me more resistant 
to that particular drug. Doctors then needs to prescribe stronger antibiotics, but the bacteria quickly learn to defend themselves against 
the more potent drugs as well, creating a cycle in which increasingly powerful drugs are required to treat infections.                                                       
Experts are working to develop new antibiotics and to keep pace with antibiotic-resistant strains of bacteria, but bacteria adapt quickly. 
Antibiotic-resistant bacteria continue to be a global health concern and using antibiotics wisely is an important part of preventing the 
development of resistance.  
 
Consequences of antibiotic resistance  
As an increasing amount of bacteria become resistant to first l ine treatments, the consequences become severe. Il lnesses last  longer, 
and the risk of complications and death increases.  The inability to properly treat a particular infection leads to longer period s in which a 
person is contagious and able to spread the resistant bacterial strains to others.                                                                                                                                                 
Because of first l ine treatment failures, doctors have to resort to less-conventional antibiotics, many of which are much more costly and 
have more side-effects.                                                                                                                                                                               
Many other factors need to be considered, including the increased costs associated with prolonged illnesses, direct expense for 
additional laboratory tests, treatments and hospitalization, and the indirect costs from loss of income or time away from fam ily.  
Safeguard effective antibiotics: What you can do 
Finishing your prescribed course of antibiotics is utmost importance.                
Using antibiotics too often or incorrectly is a major cause of the increase in resistant bacteria. Here are some things you can do to 
promote proper use of antibiotics:  
 Understand when antibiotics should be used. Don't expect to take antibiotics every time you're sick. Antibiotics are 
effective in treating bacterial infections, but they're not useful against viral infections, such as colds, acute bronchitis,  or the flu. 
And even some common minor bacterial ailments, such as mild ear infections, don't benefit much from antibiotics.  
 Don't pressure your doctor for antibiotics if you hav e a v iral illness.   Talk to your doctor about ways to relieve the 
symptoms of your viral infection.  
 Take antibiotics exactly as prescribed. Follow your doctor's instructions when taking prescribed medication, including 
how many times a day and for how long. Never stop treatment a few days early if you start feeling better — a complete course of 
antibiotics is needed to kil l all of the harmful bacteria. A shortened course of antibiotics often only kil ls the most vulnerable 
bacteria, while allowing relatively resistant bacteria to survive.  
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 Nev er take antibiotics without a prescription.  You might be tempted to use leftover medication the next time you get 
sick. This might be the incorrect antibiotic for you infection and an incomplete course.  
 Protect yourself from infection in the first place. Good hygiene can go a long way in preventing infection. Wash your 
hands thoroughly with soap and water, especially after using the toilet, changing a diaper or handling raw meat or poultry. Keep  
food preparation areas clean.  
 
Antibiotic resistance is a pressing, global health problem. Nearly all bacterial infections are becoming resistant to commonly 
used antibiotics. When you abuse antibiotics, the resistant micro-organisms that you help create can cause new  and hard-to-
treat infections. That's w hy the decisions you make about antibiotic use — unlike almost any other medicine you take — extend 
far beyond your reach. Responsible antibiotic use protects the health of your family, neighbours and ultimately the global 
community. 
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